RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Re-analysis of modeling a switch from a 13-valent to 10-valent pneumococcal conjugate vaccine in Canada
Leveraging real-world experience from Belgium
Wasserman, M. D., Sings, H. L., Wilson, M. R., Postma, M. J., Breton, M-C., McDade, C., & Farkouh, R. A. (2018). Re-analysis of modeling a switch from a 13-valent to 10-valent pneumococcal conjugate vaccine in Canada: Leveraging real-world experience from Belgium. Infectious Diseases and Therapy. Advance online publication. https://doi.org/10.1007/s40121-018-0222-1